Vanessa atalanta chromosome 21, ilVanAtal1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Papilionoidea; Nymphalidae; Nymphalinae; Vanessa.
REFSEQ INFORMATION: The reference sequence is identical to\nLR990570.1.\nAssembly name: ilVanAtal1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Wellcome Sanger Institute on\n2021/09/28. The original whole-genome shotgun project has the\naccession CAJHWX000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vanessa atalanta Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
lutropin-choriogonadotropic hormone receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125072267, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC125072267, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
vacuolar protein sorting-associated protein 26C, transcript variant X3
vacuolar protein sorting-associated protein 26C, transcript variant X1
vacuolar protein sorting-associated protein 26C, transcript variant X2
vacuolar protein sorting-associated protein 26C isoform X2
vacuolar protein sorting-associated protein 26C isoform X1
vacuolar protein sorting-associated protein 26C isoform X3
eukaryotic translation initiation factor 2D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
GAS2-like protein 3, transcript variant X3
GAS2-like protein 3, transcript variant X1
GAS2-like protein 3, transcript variant X5
GAS2-like protein 3, transcript variant X4
GAS2-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
facilitated trehalose transporter Tret1-2 homolog, transcript variant X1
facilitated trehalose transporter Tret1-2 homolog, transcript variant X2
facilitated trehalose transporter Tret1-2 homolog isoform X1
facilitated trehalose transporter Tret1-2 homolog isoform X2
probable asparagine--tRNA ligase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable asparagine--tRNA ligase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
probable asparagine--tRNA ligase, mitochondrial isoform X1
probable asparagine--tRNA ligase, mitochondrial isoform X2
pre-mRNA cleavage complex 2 protein Pcf11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pre-mRNA cleavage complex 2 protein Pcf11, transcript variant X1
pre-mRNA cleavage complex 2 protein Pcf11 isoform X2
pre-mRNA cleavage complex 2 protein Pcf11 isoform X1
uncharacterized LOC125072299, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC125072299 isoform X1
uncharacterized LOC125072299, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC125072299 isoform X2
putative oxidoreductase GLYR1 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
putative oxidoreductase GLYR1 homolog, transcript variant X2
putative oxidoreductase GLYR1 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
putative oxidoreductase GLYR1 homolog isoform X1
putative oxidoreductase GLYR1 homolog isoform X2
putative oxidoreductase GLYR1 homolog isoform X3
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X3
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X1
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X2
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 isoform X2
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125072251, transcript variant X1
uncharacterized LOC125072251, transcript variant X2
uncharacterized protein LOC125072251 isoform X1
uncharacterized protein LOC125072251 isoform X2
uncharacterized LOC125072369, transcript variant X1
uncharacterized LOC125072369, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC125072369 isoform X1
uncharacterized protein LOC125072369 isoform X2
uncharacterized LOC125072370, transcript variant X1
uncharacterized LOC125072370, transcript variant X2
uncharacterized protein LOC125072370 isoform X1
uncharacterized protein LOC125072370 isoform X2
endoplasmic reticulum-Golgi intermediate compartment protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125072241, transcript variant X1
uncharacterized protein LOC125072241 isoform X1
uncharacterized LOC125072241, transcript variant X3
uncharacterized LOC125072241, transcript variant X2
uncharacterized protein LOC125072241 isoform X2
uncharacterized LOC125072241, transcript variant X4
uncharacterized protein LOC125072241 isoform X3
protein Fe65 homolog, transcript variant X1
protein Fe65 homolog, transcript variant X2
protein Fe65 homolog, transcript variant X3
protein Fe65 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein Fe65 homolog, transcript variant X4
protein Fe65 homolog, transcript variant X6
protein Fe65 homolog, transcript variant X7
protein Fe65 homolog, transcript variant X8
protein Fe65 homolog, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
leucine-rich repeat-containing protein 24-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
DNA polymerase subunit gamma-1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase D, transcript variant X1
peptidyl-prolyl cis-trans isomerase D, transcript variant X2
peptidyl-prolyl cis-trans isomerase D isoform X1
peptidyl-prolyl cis-trans isomerase D isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 68% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC125072189
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
E3 ubiquitin-protein ligase SH3RF1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase SH3RF1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
E3 ubiquitin-protein ligase SH3RF1 isoform X1
E3 ubiquitin-protein ligase SH3RF1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 49% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
nuclear pore complex protein NUP98B-like, transcript variant X3
nuclear pore complex protein NUP98B-like, transcript variant X2
nuclear pore complex protein NUP98B-like, transcript variant X1
nuclear pore complex protein NUP98B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear pore complex protein Nup214-like isoform X3
nuclear pore complex protein NUP98B-like isoform X1
nuclear pore complex protein NUP98B-like isoform X2
brain tumor protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
brain tumor protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
brain tumor protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
brain tumor protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
brain tumor protein, transcript variant X6
brain tumor protein, transcript variant X3
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial
malignant T-cell-amplified sequence 1 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
malignant T-cell-amplified sequence 1 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
malignant T-cell-amplified sequence 1 homolog, transcript variant X1
malignant T-cell-amplified sequence 1 homolog isoform X3
malignant T-cell-amplified sequence 1 homolog isoform X2
malignant T-cell-amplified sequence 1 homolog isoform X1
ankyrin repeat and LEM domain-containing protein 2 homolog
repetitive organellar protein-like, transcript variant X3
repetitive organellar protein-like, transcript variant X2
repetitive organellar protein-like, transcript variant X1
repetitive organellar protein-like isoform X3
repetitive organellar protein-like isoform X2
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125072238, transcript variant X1
uncharacterized LOC125072238, transcript variant X2
uncharacterized protein LOC125072238 isoform X1
uncharacterized protein LOC125072238 isoform X2
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
xylosyl- and glucuronyltransferase LARGE2s-like
intraflagellar transport protein 57 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
myosin light chain kinase, smooth muscle-like
uncharacterized LOC125072290, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125072290, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA-directed RNA polymerase III subunit RPC3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA-directed RNA polymerase III subunit RPC3, transcript variant X2
DNA-directed RNA polymerase III subunit RPC3
ubiquitin-like protein 3, transcript variant X1
ubiquitin-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cleavage and polyadenylation specificity factor subunit 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cleavage and polyadenylation specificity factor subunit 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cleavage and polyadenylation specificity factor subunit 6, transcript variant X2
cleavage and polyadenylation specificity factor subunit 6, transcript variant X3
cleavage and polyadenylation specificity factor subunit 6 isoform X1
cleavage and polyadenylation specificity factor subunit 6 isoform X4
cleavage and polyadenylation specificity factor subunit 6 isoform X2
cleavage and polyadenylation specificity factor subunit 6 isoform X3
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glutaredoxin domain-containing cysteine-rich protein CG31559-like
guanylate cyclase soluble subunit beta-1, transcript variant X2
guanylate cyclase soluble subunit beta-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
guanylate cyclase soluble subunit beta-1 isoform X2
guanylate cyclase soluble subunit beta-1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 71% coverage of the annotated genomic feature by RNAseq alignments
AT-rich interactive domain-containing protein 2, transcript variant X5
AT-rich interactive domain-containing protein 2, transcript variant X11
AT-rich interactive domain-containing protein 2, transcript variant X2
AT-rich interactive domain-containing protein 2, transcript variant X9
AT-rich interactive domain-containing protein 2, transcript variant X8
AT-rich interactive domain-containing protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
AT-rich interactive domain-containing protein 2, transcript variant X3
AT-rich interactive domain-containing protein 2, transcript variant X4
AT-rich interactive domain-containing protein 2, transcript variant X7
AT-rich interactive domain-containing protein 2, transcript variant X1
AT-rich interactive domain-containing protein 2, transcript variant X10
AT-rich interactive domain-containing protein 2 isoform X5
AT-rich interactive domain-containing protein 2 isoform X11
AT-rich interactive domain-containing protein 2 isoform X2
AT-rich interactive domain-containing protein 2 isoform X9
AT-rich interactive domain-containing protein 2 isoform X8
AT-rich interactive domain-containing protein 2 isoform X10
AT-rich interactive domain-containing protein 2 isoform X6
AT-rich interactive domain-containing protein 2 isoform X3
AT-rich interactive domain-containing protein 2 isoform X4
AT-rich interactive domain-containing protein 2 isoform X7
AT-rich interactive domain-containing protein 2 isoform X1
AF4/FMR2 family member lilli, transcript variant X5
AF4/FMR2 family member lilli, transcript variant X2
AF4/FMR2 family member lilli, transcript variant X3
AF4/FMR2 family member lilli, transcript variant X4
AF4/FMR2 family member lilli, transcript variant X1
formin-like protein 20, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
formin-like protein 20, transcript variant X2
uncharacterized protein LOC125072371 isoform X2
protein tumorous imaginal discs, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein tumorous imaginal discs, mitochondrial-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein tumorous imaginal discs, mitochondrial-like, transcript variant X1
protein tumorous imaginal discs, mitochondrial-like isoform X2
protein tumorous imaginal discs, mitochondrial-like isoform X3
protein tumorous imaginal discs, mitochondrial-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
U8-agatoxin-Ao1a-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
U8-agatoxin-Ao1a-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
cilia- and flagella-associated protein 97-like
UHRF1-binding protein 1-like, transcript variant X1
UHRF1-binding protein 1-like, transcript variant X2
protein kinase C and casein kinase II substrate protein 3, transcript variant X4
protein kinase C and casein kinase II substrate protein 3, transcript variant X5
protein kinase C and casein kinase II substrate protein 3, transcript variant X3
protein kinase C and casein kinase II substrate protein 3, transcript variant X1
protein kinase C and casein kinase II substrate protein 3, transcript variant X2
protein kinase C and casein kinase substrate in neurons protein 1 isoform X1
protein kinase C and casein kinase substrate in neurons protein 1 isoform X3
protein kinase C and casein kinase substrate in neurons protein 1 isoform X5
protein kinase C and casein kinase II substrate protein 3 isoform X2
protein kinase C and casein kinase substrate in neurons protein 1 isoform X4
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
E3 ubiquitin-protein ligase UBR1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
E3 ubiquitin-protein ligase UBR1, transcript variant X3
E3 ubiquitin-protein ligase UBR1, transcript variant X1
E3 ubiquitin-protein ligase UBR1 isoform X2
E3 ubiquitin-protein ligase UBR1 isoform X1
protein arginine methyltransferase NDUFAF7 homolog, mitochondrial
uncharacterized LOC125072312, transcript variant X2
uncharacterized LOC125072312, transcript variant X1
uncharacterized protein LOC125072312 isoform X2
uncharacterized protein LOC125072312 isoform X1
probable ATP-dependent RNA helicase Dbp45A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X5
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X4
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1, transcript variant X6
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X5
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X4
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X6
RNA-binding protein 41-like, transcript variant X2
RNA-binding protein 41-like, transcript variant X1
ecto-NOX disulfide-thiol exchanger 2-like
galactose mutarotase-like, transcript variant X1
galactose mutarotase-like, transcript variant X2
probable protein phosphatase 2C T23F11.1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable protein phosphatase 2C T23F11.1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable protein phosphatase 2C T23F11.1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable protein phosphatase 2C T23F11.1, transcript variant X5
probable protein phosphatase 2C T23F11.1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable protein phosphatase 2C T23F11.1 isoform X1
probable protein phosphatase 2C T23F11.1 isoform X2
transient-receptor-potential-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transient-receptor-potential-like protein, transcript variant X2
transient-receptor-potential-like protein isoform X1
transient-receptor-potential-like protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
ras association domain-containing protein 10, transcript variant X2
ras association domain-containing protein 10, transcript variant X1
ras association domain-containing protein 10 isoform X2
ras association domain-containing protein 10 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cyclin-dependent kinase inhibitor 1-like
homeodomain-interacting protein kinase 2-like, transcript variant X2
homeodomain-interacting protein kinase 2-like, transcript variant X1
homeodomain-interacting protein kinase 2-like isoform X2
homeodomain-interacting protein kinase 2-like isoform X1
nuclear transcription factor Y subunit alpha, transcript variant X3
nuclear transcription factor Y subunit alpha, transcript variant X1
nuclear transcription factor Y subunit alpha, transcript variant X2
nuclear transcription factor Y subunit alpha isoform X2
nuclear transcription factor Y subunit alpha isoform X1
N-alpha-acetyltransferase 15, NatA auxiliary subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
carbonic anhydrase-related protein 10, transcript variant X1
carbonic anhydrase-related protein 10, transcript variant X2
carbonic anhydrase-related protein 10 isoform X2
carbonic anhydrase-related protein 10 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
RNA polymerase II-associated factor 1 homolog
nucleosome assembly protein 1-like 1-B, transcript variant X1
nucleosome assembly protein 1-like 1-B, transcript variant X2
nucleosome assembly protein 1-like 1 isoform X1
nucleosome assembly protein 1-like 1-B isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00532
stromal interaction molecule homolog, transcript variant X2
stromal interaction molecule homolog, transcript variant X1
stromal interaction molecule homolog isoform X2
stromal interaction molecule homolog isoform X1
stromal interaction molecule homolog, transcript variant X3
stromal interaction molecule homolog isoform X3
REPTOR-binding partner, transcript variant X1
REPTOR-binding partner, transcript variant X2
protein mini spindles, transcript variant X1
protein mini spindles, transcript variant X2
zinc finger CCCH domain-containing protein 11A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 33% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
torso-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
torso-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ATPase inhibitor mai-2, mitochondrial-like
paired box protein Pax-6-like, transcript variant X1
paired box protein Pax-6-like, transcript variant X2
paired box protein Pax-6-like isoform X1
paired box protein Pax-6-like isoform X2
transmembrane 7 superfamily member 3-like
uncharacterized LOC125072364, transcript variant X2
uncharacterized protein LOC125072364 isoform X2
uncharacterized LOC125072364, transcript variant X3
uncharacterized protein LOC125072364 isoform X3
uncharacterized LOC125072364, transcript variant X4
uncharacterized LOC125072364, transcript variant X1
uncharacterized protein LOC125072364 isoform X1
uncharacterized protein LOC125072364 isoform X4
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Hermansky-Pudlak syndrome 5 protein homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable cytochrome P450 49a1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable cytochrome P450 49a1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable cytochrome P450 49a1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable cytochrome P450 49a1 isoform X1
probable cytochrome P450 49a1 isoform X2
probable cytochrome P450 49a1 isoform X3
probable cytochrome P450 301a1, mitochondrial
WD repeat domain phosphoinositide-interacting protein 4-like
uncharacterized LOC125072373, transcript variant X1
uncharacterized LOC125072373, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
multidrug resistance protein homolog 49-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
multidrug resistance protein homolog 49-like, transcript variant X2
multidrug resistance protein homolog 49-like isoform X1
multidrug resistance protein homolog 49-like isoform X2
probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial
AN1-type zinc finger protein 2A-like, transcript variant X1
AN1-type zinc finger protein 2A-like, transcript variant X2
telomere length and silencing protein 1 homolog
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
apoptosis-inducing factor 1, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 51% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00007
uncharacterized LOC125072348, transcript variant X2
uncharacterized LOC125072348, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
carboxypeptidase B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
carboxypeptidase B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase
ubiquitin-fold modifier 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ubiquitin-fold modifier 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC125072387 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
ATP-binding cassette sub-family A member 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
host cell factor 1, transcript variant X2
host cell factor 1, transcript variant X1
prothoracicostatic peptides, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
prothoracicostatic peptides, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
prothoracicostatic peptides, transcript variant X3
tRNA:m(4)X modification enzyme TRM13 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tRNA:m(4)X modification enzyme TRM13 homolog, transcript variant X2
tRNA:m(4)X modification enzyme TRM13 homolog isoform X1
tRNA:m(4)X modification enzyme TRM13 homolog isoform X2
ADP-ribosylation factor GTPase-activating protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glucosamine-6-phosphate isomerase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
glucosamine-6-phosphate isomerase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
glucosamine-6-phosphate isomerase isoform X2
glucosamine-6-phosphate isomerase isoform X1
charged multivesicular body protein 2a, transcript variant X3
charged multivesicular body protein 2a, transcript variant X1
charged multivesicular body protein 2a, transcript variant X2
charged multivesicular body protein 2a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
apoptosis-inducing factor 1, mitochondrial-like, transcript variant X1
apoptosis-inducing factor 1, mitochondrial-like, transcript variant X2
apoptosis-inducing factor 1, mitochondrial-like isoform X1
apoptosis-inducing factor 1, mitochondrial-like isoform X2